Solutions
Online Inquiry
Global Services. (Creative Biolabs Authorized)

TME CD8⁺ T Cell Metabolic Profiling Service

Online Inquiry
Background Services Highlights Applications Associated Services

CD8+ T Cell Metabolism in TME

In the tumor microenvironment, CD8+ T cells play a critical role in attacking cancer, but their success largely depends on metabolic dynamics. When CD8+ T effector cells are active, they depend on glycolysis to fuel their tumor-killing functions. If this energy pathway falters, so does their ability to eliminate cancer cells. On the other hand, tumor cells often flood the environment with lactate, a glycolysis byproduct. Excess lactate buildup can block CD8+ T cells from exporting it, stifling their growth and weakening their cancer-fighting power. This metabolic battle—where nutrients are fiercely competed over and toxic metabolites like lactate pile up—creates a harsh landscape that cripples CD8+ T cells' ability to effectively combat tumors.

Fig.1 T-cell metabolism in the TME. (OA Literature)Fig.1 The metabolic interaction between tumor cells and T effector cells.1,3

TME CD8+ T Cell Metabolic Profiling Service at Creative Biolabs

To comprehensively identify CD8+ T cell metabolism in TME, Creative Biolabs delivers a cost-effective TME CD8+ T cell metabolic profiling service to assist global customers in therapeutic target discovery and targeted therapeutics development.

In particular, our service provides a comprehensive analysis of CD8+ T cells within the TME to uncover key insights for therapeutic development. We begin by isolating and enriching CD8+ T cells from tumor tissue. Next, we delve into the metabolic landscape of these cells to quantify critical processes and intracellular metabolite levels. Meanwhile, we examine the genetic underpinnings of these metabolic states and immune responses. Specifically, we evaluate gene expression profiling to reveal the expression of metabolic pathway genes and immune checkpoint-related genes while assessing cytokine production, cytotoxicity, and proliferation to understand the functional implications. Altogether, our integrated profiling enables customers to identify key signatures and potential therapeutic targets, ultimately promoting targeted immunotherapeutics discovery and development.

Attractive Advantages

Comprehensive Analysis

Targeted Therapeutic Development

Cost-Effective Solution

Expertise and Integration

Global Accessibility

Potential Applications

  • Immunotherapy Optimization:
  • Identifying metabolic vulnerabilities of exhausted CD8+ T cells to guide the development of metabolic-targeted immunotherapies.
  • Predicting patient response to checkpoint inhibitors by assessing the metabolic fitness of tumor-infiltrating CD8+ T cells.
  • Monitoring the metabolic effects of immunotherapies to optimize treatment strategies.
  • Cancer Biomarker Discovery:
  • Identifying metabolic signatures connected with positive or poor clinical outcomes.
  • Developing diagnostic tools to assess the functional status of CD8+ T cells in the TME.
  • Stratifying patients based on their TME metabolic profiles for personalized treatment approaches.
  • Drug Development:
  • Evaluating the impact of novel cancer therapies on CD8+ T cell metabolism.
  • Screening potential immunomodulatory drugs that enhance CD8+ T cell metabolic fitness.
  • Understanding the metabolic interactions between tumor cells, CD8+ T cells, and other TME components.
  • Basic Research:
  • Elucidating the metabolic pathways that regulate CD8+ T cell function in the TME.
  • Investigating the role of metabolic competition and nutrient availability in T cell exhaustion.
  • Exploring the metabolic adaptations of CD8+ T cells in different cancer types.
  • Personalized medicine:
  • Using the metabolic profiles to design personalized immunotherapies.
  • Using the metabolic profiles to predict the likelihood of success of certain therapies.

Associated Services

Moving beyond standard TME CD8+ T cell metabolic profiling, our services explore the intricate interplay of metabolic rewiring in these immune effectors. We deliver comprehensive characterization of physiological metabolic adaptations triggered by diverse stimuli, shedding light on their adaptation mechanisms across diverse physiological contexts. Our customized analytical framework incorporates specialized metrics—from real-time amino acid utilization rates to glucose transporter dynamics—that pinpoint nutrient dependencies and expose metabolic liabilities governing CD8+ T cell efficacy. This granular, pathway-centric approach empowers researchers to map rate-limiting metabolic nodes and engineer precision interventions for fine-tuning T cell behavior in both homeostasis and disease pathogenesis.


If you are looking for a reliable company to characterize interested TME CD8+ T cells and evaluate the effectiveness of developed therapeutics, please don't hesitate to get in touch with us.

Reference

  1. Ping, Yu, et al. "Reprogramming T-Cell metabolism for better anti-tumor immunity." Cells 11.19 (2022): 3103. Distributed under Open Access License CC BY 4.0, without modification.
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.